NOS1AP protein levels are altered in BA46 and cerebellum of patients with schizophrenia

Norell M. Hadzimichalis; Michelle L. Previtera; Michael P. Moreau; Bo Li; Gum Hwa Lee; Anna M. Dulencin; Paul G. Matteson; Steven Buyske; James H. Millonig; Linda M. Brzustowicz; Bonnie L. Firestein

doi:10.1016/j.schres.2010.05.009

NOS1AP protein levels are altered in BA46 and cerebellum of patients with schizophrenia

Norell M. Hadzimichalis
, Michelle L. Previtera
, Michael P. Moreau
, Bo Li
, Gum Hwa Lee
, Anna M. Dulencin
, Paul G. Matteson
, Steven Buyske
, James H. Millonig
, Linda M. Brzustowicz
, Bonnie L. Firestein

Pharmacology and Nutritional Sciences

Research output: Contribution to journal › Letter › peer-review

29 Scopus citations

Original language	English
Pages (from-to)	248-250
Number of pages	3
Journal	Schizophrenia Research
Volume	124
Issue number	1-3
DOIs	https://doi.org/10.1016/j.schres.2010.05.009
State	Published - Dec 2010

Funding

Funding for this study was provided by NIAAA grant K25 AA015346 (to S.B.), NARSAD Young Investigator Award (to J.H.M), NIMH grant R01 MH062440 and the NARSAD/Staglin Family Music Festival Schizophrenia Research Award (to L.M.B.), and NARSAD 2007 Toulmin Independent Investigator Award and NSF grant IBN-0548543 and IBN-0919747 (to B.L.F). M.L.P. was supported by the IGERT Program on Biointerfaces-NSF grant DGE-0333196 and Louis Bevier Dissertation Fellowship. Human postmortem tissue specimens were obtained from the Human Brain and Spinal Fluid Resource Center, VA West Los Angeles Healthcare Center, 11301 Wilshire Blvd, Los Angeles, CA 90073, which is sponsored by NINDS/NIMH, National Multiple Sclerosis Society, and the Department of Veterans Administration. We thank Dr. Erik Charych for initial Western blotting studies using actin as a control.

Funders	Funder number
IGERT Program on Biointerfaces NSF	DGE-0333196
Staglin
National Science Foundation	IBN-0919747, IBN-0548543
National Institute of Mental Health	R01MH062440
National Institute on Alcohol Abuse and Alcoholism	K25 AA015346
National Alliance for Research on Schizophrenia and Depression

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

ASJC Scopus subject areas

Psychiatry and Mental health
Biological Psychiatry

Access to Document

10.1016/j.schres.2010.05.009

Cite this

@article{62ca9bdeff584071a56030acc6154167,

title = "NOS1AP protein levels are altered in BA46 and cerebellum of patients with schizophrenia",

author = "Hadzimichalis, \{Norell M.\} and Previtera, \{Michelle L.\} and Moreau, \{Michael P.\} and Bo Li and Lee, \{Gum Hwa\} and Dulencin, \{Anna M.\} and Matteson, \{Paul G.\} and Steven Buyske and Millonig, \{James H.\} and Brzustowicz, \{Linda M.\} and Firestein, \{Bonnie L.\}",

year = "2010",

month = dec,

doi = "10.1016/j.schres.2010.05.009",

language = "English",

volume = "124",

pages = "248--250",

number = "1-3",

}

TY - JOUR

T1 - NOS1AP protein levels are altered in BA46 and cerebellum of patients with schizophrenia

AU - Hadzimichalis, Norell M.

AU - Previtera, Michelle L.

AU - Moreau, Michael P.

AU - Li, Bo

AU - Lee, Gum Hwa

AU - Dulencin, Anna M.

AU - Matteson, Paul G.

AU - Buyske, Steven

AU - Millonig, James H.

AU - Brzustowicz, Linda M.

AU - Firestein, Bonnie L.

PY - 2010/12

Y1 - 2010/12

UR - https://www.scopus.com/pages/publications/78249244119

UR - https://www.scopus.com/pages/publications/78249244119#tab=citedBy

U2 - 10.1016/j.schres.2010.05.009

DO - 10.1016/j.schres.2010.05.009

M3 - Letter

C2 - 20605702

AN - SCOPUS:78249244119

SN - 0920-9964

VL - 124

SP - 248

EP - 250

JO - Schizophrenia Research

JF - Schizophrenia Research

IS - 1-3

ER -

NOS1AP protein levels are altered in BA46 and cerebellum of patients with schizophrenia

Funding

UN SDGs

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this